Chiara Mercinelli (@cmercinelli) 's Twitter Profile
Chiara Mercinelli

@cmercinelli

Genito-Urinary Medical Oncologist at IRCCS San Raffaele Hospital - PhD Candidate in Molecular Medicine at Vita-Salute San Raffaele University

ID: 871449401268555776

calendar_today04-06-2017 19:31:42

179 Tweet

363 Followers

286 Following

Giuseppe Banna (@gbanna74) 's Twitter Profile Photo

Nice to have had the chance to meet and catch up with fantastic colleagues during #EAU25! Always great discussions and new ideas with Jeremy Teoh Vérane Achard Chiara Mercinelli Brigida Maiorano Nello Cimino. Looking forward to future collaborations! #UroOncology #Networking

Nice to have had the chance to meet and catch up with fantastic colleagues during #EAU25! Always great discussions and new ideas with Jeremy Teoh <a href="/Achard_Verane/">Vérane Achard</a> Chiara Mercinelli <a href="/BrigidaMaiorano/">Brigida Maiorano</a> Nello Cimino. Looking forward to future collaborations! #UroOncology #Networking
Chiara Mercinelli (@cmercinelli) 's Twitter Profile Photo

Deeply honored to have been selected for the #ASCO2025 #MeritAward for our work on #NureCombo ➡️ Once again, many thanks to the Conquer Cancer, the ASCO Foundation and to my mentor, Prof. Andrea Necchi for the incredible opportunity! Ospedale San Raffaele See you in Chicago!✨ ASCO

Andrea Necchi (@andreanecchi) 's Twitter Profile Photo

#SURE02 interim results will be disclosed at #ASCO25 #RapidOral session The trial provides SG-Pembro > bladder sparing for cCR > maintenance pembro to pts with MIBC Interim cCR survival and biomarker data will be presented Ospedale San Raffaele Università Vita-Salute San Raffaele Veracyte, Inc. Foundation Medicine

#SURE02 interim results will be disclosed at #ASCO25 #RapidOral session 
The trial provides SG-Pembro &gt; bladder sparing for cCR &gt; maintenance pembro to pts with MIBC 
Interim cCR survival and biomarker data will be presented <a href="/SanRaffaeleMI/">Ospedale San Raffaele</a> <a href="/MyUniSR/">Università Vita-Salute San Raffaele</a> <a href="/Veracyte/">Veracyte, Inc.</a> <a href="/FoundationATCG/">Foundation Medicine</a>
LARVOL (@larvol) 's Twitter Profile Photo

The Top 10 Trials in GU Cancer for April 2025 are here, highlighted by LARVOL CLIN. #LARVOL #Oncology #GUCancer #GenitourinaryCancer #CancerResearch #ClinicalTrials #OncologyInsights | Toni Choueiri, MD | Tom Powles Yüksel Ürün | Sumanta K. Pal, MD, FASCO | Petros Grivas | Neeraj Agarwal, MD, FASCO |

The Top 10 Trials in GU Cancer for April 2025 are here, highlighted by <a href="/Larvol/">LARVOL</a> CLIN.

#LARVOL #Oncology #GUCancer #GenitourinaryCancer #CancerResearch #ClinicalTrials #OncologyInsights | <a href="/DrChoueiri/">Toni Choueiri, MD</a> | <a href="/tompowles1/">Tom Powles</a>   <a href="/DrYukselUrun/">Yüksel Ürün</a> | <a href="/montypal/">Sumanta K. Pal, MD, FASCO</a> | <a href="/PGrivasMDPhD/">Petros Grivas</a> | <a href="/neerajaiims/">Neeraj Agarwal, MD, FASCO</a> |
Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo

Ab#4518 ASCO #ASCO25 by Andrea Necchi 👉 bit.ly/43HuZI7👉Ph2 SURE-02 trial of neo-adj SG-pembro --> adj pembro in pts w/ MIBC #bladdercancer 👉clinical CR in ~39% of pts, allowing bladder preservation👇Francesco Montorsi Chiara Mercinelli Valentina Tateo OncoAlert UroToday.com

Ab#4518 <a href="/ASCO/">ASCO</a> #ASCO25 by <a href="/AndreaNecchi/">Andrea Necchi</a> 👉 bit.ly/43HuZI7👉Ph2 SURE-02 trial of neo-adj SG-pembro --&gt; adj pembro in pts w/ MIBC #bladdercancer 👉clinical CR in ~39% of pts, allowing bladder preservation👇<a href="/F_Montorsi/">Francesco Montorsi</a> <a href="/CMercinelli/">Chiara Mercinelli</a> <a href="/vale_tateo/">Valentina Tateo</a>  <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a>
Chiara Mercinelli (@cmercinelli) 's Twitter Profile Photo

Thanks VJ Oncology for the interview today at #ASCO25 It was a pleasure to discuss #NUREcombo updated results & share insights on our work on #bladdercancer at Ospedale San Raffaele Grateful for the opportunity!

Toni Choueiri, MD (@drchoueiri) 's Twitter Profile Photo

📢 #ASCO25 | SURE-02 Ph. II | Interim Results – SG + Pembro in CT-ineligible MIBC (n=40): cCR 38.7% (bladder preserved ~40%), ypT≤1 rate 51.6%; G≥3 AEs 12.9%. Luminal/GU tumors show highest ypT0; stromal signature linked to non-response. Insightful work by Andrea Necchi et al.

📢 #ASCO25 | SURE-02 Ph. II | Interim Results – SG + Pembro in CT-ineligible MIBC (n=40): cCR 38.7% (bladder preserved ~40%), ypT≤1 rate 51.6%; G≥3 AEs 12.9%. Luminal/GU tumors show highest ypT0; stromal signature linked to non-response. Insightful work by <a href="/AndreaNecchi/">Andrea Necchi</a> et al.
Chiara Mercinelli (@cmercinelli) 's Twitter Profile Photo

My mentor Andrea Necchi delivered a brilliant presentation today at #ASCO2025 ➡️ 44% cCR in MIBC with SG+P combination in #SURE2 trial ➡️promising biomarker results that could guide future therapeutic choices ⭐️So proud to be part of this wonderful team Ospedale San Raffaele #GUoncology

My mentor <a href="/AndreaNecchi/">Andrea Necchi</a> delivered a brilliant presentation today at #ASCO2025 ➡️ 44% cCR in MIBC with SG+P combination in #SURE2 trial ➡️promising biomarker results that could guide future therapeutic choices
⭐️So proud to be part of this wonderful team <a href="/SanRaffaeleMI/">Ospedale San Raffaele</a> #GUoncology
Andrea Necchi (@andreanecchi) 's Twitter Profile Photo

The one and only Shilpa Gupta rocks the stage as usual with subgroup analyses of #EV302 Excellent and lively presentation with you at the Oral Abstract session! ASCO #ASCO25

The one and only <a href="/shilpaonc/">Shilpa Gupta</a> rocks the stage as usual with subgroup analyses of #EV302 Excellent and lively presentation with you at the Oral Abstract session! <a href="/ASCO/">ASCO</a> #ASCO25
Alessandro Volpe (@foxal72) 's Twitter Profile Photo

#UROonco25 starting today in the beautiful city of #Sevilla. Top experts from Europe and beyond come together to discuss about diagnosis and treatment of GU cancers. #ProstateCancer #KidneyCancer #BladderCancer Knowledge sharing and latest research with the common goal to

#UROonco25 starting today in the beautiful city of #Sevilla.  Top experts from Europe and beyond come together to discuss about diagnosis and treatment of GU cancers. #ProstateCancer #KidneyCancer #BladderCancer Knowledge sharing and latest research with the common goal to
Chiara Mercinelli (@cmercinelli) 's Twitter Profile Photo

Just back from #UROonco25 in the stunning Seville! Honoured to be invited ➡️ a fantastic chance to dive into the latest in uro-oncology and catch up with friends and colleagues. European Association of Urology (EAU) OncoDaily UroFocus Ospedale San Raffaele

Just back from #UROonco25 in the stunning Seville! Honoured to be invited ➡️ a fantastic chance to dive into the latest in uro-oncology and catch up with friends and colleagues.

<a href="/Uroweb/">European Association of Urology (EAU)</a> <a href="/oncodaily/">OncoDaily</a> <a href="/urofocus/">UroFocus</a> <a href="/SanRaffaeleMI/">Ospedale San Raffaele</a>
Bladder Cancer Advocacy Network (@bladdercancerus) 's Twitter Profile Photo

Video in @UroToday: Zach Klaassen interviews Andrea Necchi about MRI radiomics analysis from the PURE-01 study: 3 cycles of neoadjuvant pembrolizumab in MIBC with pre- and post-treatment MRI imaging in 112 patients. Click to watch: urotoday.com/categories-med…

Mirrors of Medicine (@mirrorsmed) 's Twitter Profile Photo

Impact of molecular androgen and estrogen response scores on outcomes following neoadjuvant pembrolizumab in muscle-invasive #BladderCancer aacrjournals.org/clincancerres/… This post-hoc analysis of the PURE-01 trial investigated the influence of androgen and estrogen genomic signatures

Impact of molecular androgen and estrogen response scores on outcomes following neoadjuvant pembrolizumab in muscle-invasive #BladderCancer

aacrjournals.org/clincancerres/…

This post-hoc analysis of the PURE-01 trial investigated the influence of androgen and estrogen genomic signatures
Chiara Mercinelli (@cmercinelli) 's Twitter Profile Photo

Proud to share that I’m officially part of the EAU YAU Prostate Cancer Working Group working group of the European Association of Urology (EAU) It’s a great honour to be part of this international network ➡️ truly looking forward to growing through this experience!

Proud to share that I’m officially part of the <a href="/EAU_YAUProstate/">EAU YAU Prostate Cancer Working Group</a> working group of the <a href="/Uroweb/">European Association of Urology (EAU)</a> 

It’s a great honour to be part of this international network ➡️ truly looking forward to growing through this experience!